Maureen Ohlhausen

Maureen K. Ohlhausen chairs Baker Botts’ Global Antitrust and Competition practice. Her practice focuses on antitrust, privacy and data security and consumer protection investigations and litigation both in the U.S. and abroad. Ms. Ohlhausen joined the firm after leading the Federal Trade Commission as Acting Chairman and Commissioner. She directed all aspects of the FTC’s antitrust work, including merger review and conduct enforcement, and steered all FTC consumer protection enforcement, with a particular emphasis on privacy and technology issues. A thought leader, Ms. Ohlhausen has published dozens of articles on antitrust, privacy, IP, regulation, FTC litigation, telecommunications, and international law issues in prestigious publications and has testified over a dozen times before the U.S. Congress.

Ms. Ohlhausen has relationships with officials in the U.S. and abroad, with a particular emphasis on Europe and China, and has led the U.S. delegation at international antitrust and data privacy meetings on many occasions. She has received numerous awards, including the FTC’s Robert Pitofsky Lifetime Achievement Award.  Prior to her role as Commissioner, Ms. Ohlhausen led the FTC’s Internet Access Task Force, which produced an influential report analyzing competition and consumer protection legal issues in the areas of broadband and Internet.

In private practice, she headed the FTC practice group at a leading telecommunications firm, representing and counseling telecommunications and technology clients on antitrust compliance, privacy, and consumer protection matters before the FTC and the FCC. She also clerked at the U.S. Court of Appeals for the D.C. Circuit.

When AI Helps Generate Inventions, Who Is the Inventor?

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,
Read More

Standard Essential Patents and European Economic Security

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual
Read More

Proposed Federal Use of March-in Rights Would Weaken American Innovation

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of
Read More